Price Chart

DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
10/18/2022 -- Results Q3 2022 -- 2.55 --
10/18/2022 08:30 EST Earnings Call Q3 2022 -- -- --
07/19/2022 08:30 EST Earnings Call Q2 2022 -- -- --
07/19/2022 -- Results Q2 2022 2.59 2.55 1.63%
04/19/2022 -- Results Q1 2022 2.67 2.57 4.08%
04/19/2022 08:30 EST Earnings Call Q1 2022 -- -- --
01/25/2022 -- Results Q4 2021 2.13 2.12 0.53%
01/25/2022 08:30 EST Earnings Call Q4 2021 -- -- --
*Estimated Date/Time

Earnings

Next Report Date 10/18/2022
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 07/19/2022
Beat/Miss Upgrade
Return Since -4.30%
Last FQE 06/30/2022
Next FQE 09/30/2022

Profile

Edit
Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women’s health. Geographically, just over half of total revenue is generated in the United States.
URL https://www.jnj.com
Investor Relations URL https://www.investor.jnj.com
HQ State/Province New Jersey
Sector Healthcare
Industry Drug Manufacturers - General
Equity Style Large Cap/Blend
Next Earnings Release Oct. 18, 2022
Last Earnings Release Jul. 19, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Aug. 22, 2022

Dividends

Dividend Per Share (TTM) 4.31
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 1.827
Yield to Sector 1.454
Yield to Industry 0.7259
Last Dividend Amt. 1.13
Dividend Frequency Quarterly
Last Ex-Dividend Date Aug. 22, 2022
Yield (TTM) 2.64%
Forward Yield 2.73%
Payout Ratio 61.74%
Cash Payout Ratio 56.84%
Consistent Payer (5Y) Yes
Consistent Growth (5Y) Yes

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
1.16%
15.32%
24.40%
-5.14%
16.21%
10.85%
11.45%
-2.73%
1.38%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-21.90%
--
--
--
--
28.09%
434.1%
143.1%
-52.36%
25.37%
-10.37%
17.83%
40.45%
16.15%
31.06%
66.08%
17.66%
-3.72%
15.23%
-1.33%
40.20%
22.42%
-7.07%
1.86%
17.11%
7.30%
4.68%
16.13%
25.06%
-6.73%
3.51%
66.74%
-23.49%
As of October 03, 2022.

Profile

Edit
Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women’s health. Geographically, just over half of total revenue is generated in the United States.
URL https://www.jnj.com
Investor Relations URL https://www.investor.jnj.com
HQ State/Province New Jersey
Sector Healthcare
Industry Drug Manufacturers - General
Equity Style Large Cap/Blend
Next Earnings Release Oct. 18, 2022
Last Earnings Release Jul. 19, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Aug. 22, 2022

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

Symbol Dollars Invested % Weight
VIG 2.650B USD 3.60%
VYM 1.803B USD 3.10%
VIVAX 3.714B USD 2.58%
VTV 3.714B USD 2.58%
CWMFX 2.881B USD 1.97%
IVV 3.846B USD 1.41%
FXAIX 4.931B USD 1.32%
VINIX 3.084B USD 1.27%
VFINX 9.544B USD 1.26%
VOO 9.544B USD 1.26%
VTSMX 12.59B USD 1.07%
VTI 12.59B USD 1.07%

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Morningstar Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter JNJ Tweets